BioMathematica
Latest round
- Seed
Last raised
- Jun 2018
Total raised
- Undisclosed
Investors
- 1
About BioMathematica
Founded in 2017, BioMathematica operates out of France and specializes in bioinformatics and Systems Biology. The company has experienced growth through its unique service offerings.Biomathematica specializes in bioinformatics and Systems Biology, focusing on the application of mathematics to complex biological systems, particularly the human microbiome. The company offers an array of services, including end-to-end bioinformatics pipelines for Next Generation Sequencing (NGS) data, addressing various biological analyses such as amplicon sequencing, shotgun metagenomics, metatranscriptomics, metabolomics, and metaproteomics. Their core services are designed to analyze raw data and generate comprehensive analysis reports, facilitating the development of probiotics, prebiotics, and live biotherapeutics targeted at diverse microbiomes including human, animal, and environmental. Biomathematica caters to a diverse clientele across the biotechnology and pharmaceutical sectors, with applications spanning therapeutic development, personalized medicine, and microbiome engineering.Biomathematica's revenue model is structured around B2B transactions, engaging with clients in the life sciences and healthcare sectors through partnerships and tailored R&D projects. The company offers customized pricing plans based on specific project requirements, which may include subscription-based services for ongoing bioinformatics support or one-time fees for specific analyses related to NGS data. Their flagship offerings involve the development of mathematical models and bioinformatics pipelines that aid in microbial community analysis and in pharmacokinetics and pharmacodynamics modeling for drug development targeting the microbiome.Looking ahead, BioMathematica is focused on launching new bioinformatics products aimed at enhancing its service offerings. The company is also pursuing expansion into new markets, particularly targeting regions in Asia by the end of 2024.
Who invested in BioMathematica
1 investor across 1 round
See all investors in BioMathematica
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jun 15, 2018
Amount
Undisclosed
Investors
Questions about BioMathematica
Who invested in BioMathematica?
BioMathematica has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BioMathematica raised?
BioMathematica has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did BioMathematica last raise money?
BioMathematica's most recent round on record is a Seed, in Jun 2018.
What does BioMathematica do?
Founded in 2017, BioMathematica operates out of France and specializes in bioinformatics and Systems Biology.
Where is BioMathematica headquartered?
BioMathematica is headquartered in France.
Which VCs invest in companies like BioMathematica?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at BioMathematica's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like BioMathematica? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.